CD47 and cancer: In conclusion, it can be stated that within a cancer gene therapy approach the tumor-restricted expression of a secreted, highly effective CD47-blocking protein in conjunction with an Fc part for maximized ADCC and CDC can result in a potent antitumoral response concomitant with activation of both macrophages and NK cells.